WVP
BIOL

Worth Venture Partners’s Biolase, Inc. BIOL Stock Holding History

Worth Venture Partners’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-226
Closed -$212K – 145
2020
Q1 		$212K Buy
226
+16
+8% +$24.9K 0.13% 74
2019
Q4 		$290K Buy
+210
New +$323K 0.14% 63

Other funds holding BIOL

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Worth Venture Partners's BIOL Position: Q2 2020 in Review

Worth Venture Partners sold out of Biolase, Inc. (BIOL) in Q2 2020, closing a stake of 226 shares — an estimated $212K sold.

Worth Venture Partners first reported a position in BIOL in Q4 2019 and held it in 2 quarters. The position peaked at $290K in Q4 2019. 21 funds tracked by Wall St. Rank hold BIOL as of Q2 2020.

  • Worth Venture Partners reported no remaining Biolase, Inc. position as of Q2 2020 after selling out during the quarter.
  • Worth Venture Partners sold 226 Biolase, Inc. shares in Q2 2020, an estimated $212K.
  • Worth Venture Partners first reported a position in Biolase, Inc. in Q4 2019 and held it in 2 quarters.
  • Worth Venture Partners's Biolase, Inc. position peaked at $290K in Q4 2019.
  • 21 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2020.

Based on Worth Venture Partners's 13F filing for Q2 2020, filed 14 Aug 2020.